|
CEP170L expression based on
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.61349997199289E-09 |
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24399999693148E-08 |
| Normal-vs-Stage2 |
1.522060E-03 |
| Normal-vs-Stage3 |
4.36529999999768E-05 |
| Normal-vs-Stage4 |
2.199900E-04 |
| Stage1-vs-Stage2 |
6.461800E-01 |
| Stage1-vs-Stage3 |
6.097800E-01 |
| Stage1-vs-Stage4 |
5.567400E-01 |
| Stage2-vs-Stage3 |
9.464600E-01 |
| Stage2-vs-Stage4 |
4.076600E-01 |
| Stage3-vs-Stage4 |
3.891000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.52489995578031E-09 |
| Normal-vs-AfricanAmerican |
4.658700E-03 |
| Normal-vs-Asian |
5.566400E-02 |
| Caucasian-vs-AfricanAmerican |
8.901600E-01 |
| Caucasian-vs-Asian |
7.807000E-01 |
| AfricanAmerican-vs-Asian |
6.382800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.05210000500966E-08 |
| Normal-vs-Female |
5.88299999826347E-08 |
| Male-vs-Female |
6.741800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.258000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.3889999995782E-07 |
| Normal-vs-Age(61-80Yrs) |
1.6307999950449E-08 |
| Normal-vs-Age(81-100Yrs) |
8.984100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.848000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.500400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.242430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.299400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.851600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.957600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.043100E-04 |
| Normal-vs-Grade 2 |
1.25619999957749E-07 |
| Normal-vs-Grade 3 |
1.50755999999141E-05 |
| Normal-vs-Grade 4 |
2.00709999998994E-05 |
| Grade 1-vs-Grade 2 |
5.231400E-01 |
| Grade 1-vs-Grade 3 |
4.806400E-01 |
| Grade 1-vs-Grade 4 |
5.932800E-01 |
| Grade 2-vs-Grade 3 |
6.654600E-01 |
| Grade 2-vs-Grade 4 |
8.947800E-02 |
| Grade 3-vs-Grade 4 |
6.035800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.36450000082422E-08 |
| Normal-vs-ccB subtype |
9.98480000014013E-07 |
| ccA subtype-vs-ccB subtype |
6.491600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74260000055327E-08 |
| Normal-vs-N1 |
3.507600E-02 |
| N0-vs-N1 |
1.930180E-01 |
|
|
